Work

Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), reduction in ulcer complications: randomised controlled trial

Year: 2004

Type: article

Study design: Clinical Trial

Source: The Lancet

DOI: 10.1016/s0140-6736(04)16893-1

Authors: Thomas J Schnitzer, Gerd R Burmester, Eduardo Mysler, Marc C Hochberg, Michael Doherty, Elena Ehrsam, Xavier Gitton, Gerhard Krammer, Bernhard Mellein, Patrice Matchaba, Alberto Gimona, Christopher J Hawkey

Institutions: Northwestern University, Humboldt-Universität zu Berlin, Charité – Universitätsmedizin Berlin, University of Maryland, Baltimore, University of Nottingham, Nottingham City Hospital, Novartis (Switzerland), Nottingham University Hospitals NHS Trust

Language: English

Topic: Inflammatory mediators and NSAID effects

Subfield: Pharmacology (medical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Novartis

OpenAlex ID: W2104379105

FWCI: 45.57

Cites: 40

Cited by: 697

Related to: 10